Erelel, M. Et Al. 2021. Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial. PHARMACEUTICS , vol.13, no.11 .

Erelel, M., Kaskal, M., Akbal-Dagistan, Ö., Issever, H., Dagistanli, A. S., Balkanci, H., ... Oguz, M. S.(2021). Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial. PHARMACEUTICS , vol.13, no.11.

Erelel, Mustafa Et Al. "Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial," PHARMACEUTICS , vol.13, no.11, 2021

Erelel, Mustafa Et Al. "Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial." PHARMACEUTICS , vol.13, no.11, 2021

Erelel, M. Et Al. (2021) . "Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial." PHARMACEUTICS , vol.13, no.11.

@article{article, author={Mustafa Erelel Et Al. }, title={Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial}, journal={PHARMACEUTICS}, year=2021}